The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients

NCT01397240 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Patients Taking Low-dose Aspirin

Interventions

DRUG: Albis Tab
DRUG: Placebo

Sponsor

Daewoong Pharmaceutical Co. LTD.